acute myeloid leukemia (AML) | Page 34 | Aplastic Anemia & MDS International Foundation Return to top.

acute myeloid leukemia (AML)

Jodi Mayfield, MD, MS

Mayfield, Jodi
Assistant Professor, Department of Pediatrics, Division of Pediatric Hematology & Oncology
University of New Mexico Comprehensive Cancer Center

Dr. Jodi Mayfield is an Assistant Professor of Pediatric Hematology/Oncology and Stem Cell research at the University of New Mexico. She received her MD from the University of New Mexico Health Sciences Center in 2008. She is currently a member of the American Society of Hematology and the Children's Oncology Group. Dr. Mayfield's areas of practice include Stem Cell transplantation, Acute Leukemias, and

Online Profile: 
http://cancer.unm.edu/member/unmmayfieldj/

Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia

Author(s): 
Lu Y, Sun RJ, Zhao YL, Xiong M, Cao XY, Zhang JP, Wei ZJ, Zhou JR, Liu DY, Lu DP
Primary Author: 
Lu Y
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
May 2018

Salvage haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is considered in patients with severe

Bone Marrow Disease(s): 

Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome

Author(s): 
Slade M, DiPersio J, Westervelt P, Vij R, Schroeder M, Romee R
Primary Author: 
Slade M
Journal Title: 
Biology of Blood and Marrow Transplantation
Original Publication Date: 
Nov 2017

Many hematologic malignancies are diseases of aging, and the use of hematopoietic cell transplant (HCT) is growing rapidly among older adults. Modern post-transplant

Bone Marrow Disease(s): 
Share with addtoany.com.